Dendritic Anomalies in Disorders Associated with Mental Retardation

Walter E. Kaufmann1,2,3,4,5 and Hugo W. Moser2,3,5

1 Departments of Pathology, , 2 Neurology, , 3 Pediatrics, and , 4 Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine and the , 5 Kennedy Krieger Institute, 707 N. Broadway, Baltimore, MD 21205, USA


    Abstract
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
Dendritic abnormalities are the most consistent anatomical correlates of mental retardation (MR). Earliest descriptions included dendritic spine dysgenesis, which was first associated with unclassified MR, but can also be found in genetic syndromes associated with MR. Genetic disorders with well-defined dendritic anomalies involving branches and/or spines include Down, Rett and fragile-X syndromes. Cytoarchitectonic analyses also suggest dendritic pathology in Williams and Rubinstein-Taybi syndromes. Dendritic abnormalities appear to have syndrome-specific pathogenesis and evolution, which correlate to some extent with their cognitive profile. The significance of dendritic pathology in synaptic circuitry and the role of animal models in the study of MR-associated dendritic abnormalities are also discussed. Finally, a model of genotype to neurologic phenotype pathway in MR, centered in dendritic abnormalities, is postulated.


    Introduction
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
Since the early 1970s, the application of dendritic labeling techniques has shown that abnormalities of this postsynaptic neuronal process are common in genetic and environmental conditions associated with mental retardation (MR) [reviewed by Huttenlocher and Kaufmann (Huttenlocher, 1991Go; Kaufmann, 1996Go)]. Although these studies have been quite informative, their limitations in terms of number of examined disorders, sample size and tissue preservation have precluded definitive conclusions about the nature and specificity of dendritic anomalies in MR. The recent identification of the genetic bases of several prevalent MR-associated disorders, combined with the accompanying generation of animal models by transgenic technology, makes the elucidation of the neuronal phenotype of these disorders even more compelling.

For the purposes of this review, we will define as ‘MR-associated disorders’ those conditions characterized by a non-progressive global cognitive deficit (e.g. Down syndrome, DS). We will focus on genetic syndromes, because they provide the potential for understanding the pathogenetic mechanisms of dendritic anomalies, and will also make some reference to childhood degenerative disorders that during their evolution display a cognitive profile that resembles MR (Kaufmann, 1996Go). The review includes a survey of disorders associated with dendritic anomalies, analyses of the relationships between dendritic pathology, cognitive phenotype and synaptic abnormalities, and the characterization of dendritic pathology in animal models relevant to MR. We conclude with a proposal for pathways linking specific gene mutations and dendritic phenotype.


    Dendritic Spine Dysgenesis and Unclassified MR
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
The pioneering studies with Golgi impregnations by Huttenlocher (Huttenlocher, 1970Go, 1974Go) and Purpura (Purpura, 1975aGo,bGo) established the foundations for the assessment of dendrites in MR. The importance of these investigations is underscored by the fact that standard neuropathological methods, which had provided critical information about the biological bases of many neurological diseases (e.g. Parkinson disease) (Hornykiewicz, 1963Go), had failed to disclose specific abnormalities in many cases of MR (Freytag and Lindenberg, 1967Go; Crome and Stern, 1972Go; Jellinger, 1972Go). The ‘rediscovered’ Golgi method demonstrated two fundamental abnormalities in the cerebral cortex: reduction in number and length of dendritic branches and the aberrant morphology and number of dendritic spines (Huttenlocher, 1970Go, 1974Go; Purpura, 1974Go, 1975aGo, bGo). Most of the evaluations focused on pyramidal neurons, which constitute the majority of the neurons in human neocortex (Crosby et al., 1962Go). In these cells, both apical and basilar branches were noted to be shorter or less complex in the brains of persons with unclassified MR. The most consistent and intriguing findings involved the shape and length of dendritic spines. The latter were not only sparse but also long and thin and, when compared with controls of different ages, resembled immature dendritic spine patterns (Purpura, 1974Go). Following these initial descriptions, this type of dendritic anomaly—referred to as spine ‘dysgenesis’—was reported by Marin-Padilla in chromosomopathies associated with MR (see Figure 1Go) (Marin-Padilla, 1972Go, 1974Go, 1976Go). Recent investigations in children and adolescents with unclassified MR have confirmed reduced density and spine dysgenesis involving apical dendrites of the prefrontal cortex (von Bossanyi and Becher, 1990Go). However, the significance of dendritic spine abnormalities in unclassified MR is not yet clear. Changes in dendritic shafts are not necessarily present in every case. Huttenlocher, in his 1991 review on the subject, emphasized that in brains from adolescents with moderate to profound MR dendrites branches appeared comparable to normal controls (Huttenlocher, 1974Go, 1991Go). Williams et al. also found this to be the case in a qualitative study of autistic individuals with MR (Williams et al., 1980Go). The extent to which age or degree of MR plays a role in dendritic arborization reduction in MR is still unknown. These initial investigations thus provided intriguing leads that MR is associated with dendritic abnormalities, but did not furnish definitive information with respect to their significance.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 1.  Dendritic spine abnormalities in Patau syndrome and DS. Drawings are from Golgi preparations depicting comparable segments of apical dendrites from layer V pyramidal neurons (motor cortex). (A–E) Different developmental stages in normal subjects (5th gestational month, 7th gestational month, neonatal period, 2nd postnatal month, 8th postnatal month, respectively). (F) A newborn with 13–15 trisomy. (G) An 18-month-old infant with DS (trisomy 21). Note the progressive increase in spine density, associated with a reduction in spine length, during normal development. Spines in Patau syndrome are not only sparse, but also longer than expected for a neonate. On the other hand, the infant with DS had shorter and thinner rather than long spines. Reprinted with permission (Marin-Padilla, 1972Go).

 
A strength of these pioneering studies resides in the combination of post-mortem and biopsy material. The latter, by eliminating the effects of post-mortem degradation, not only allowed optimal conditions for the Golgi material but also provided the opportunity for high-quality ultrastructural analyses. Purpura and collaborators (Purpura et al., 1982Go) reported that varicosities in dendrites of both pyramidal and non-pyramidal neurons were associated with the spine changes described above and with disruption in microtubule organization. By 3-D reconstructions of these microtubular disarrays, these authors demonstrated that microtubular changes underlie dendritic irregularities and that they represent aberrant crosslinking of cytoskeletal elements (Bodick et al., 1982Go). Even though these data on unclassified MR provided a strong base for understanding the role of dendritic pathology in MR, the lack of definition of etiology made the delineation of pathogenetic mechanisms difficult. Many cases classified as ‘MR of unknown cause’ two or three decades ago, can now be defined in respect to etiology. For instance, the study by Williams and colleagues (Williams et al., 1980Go) included a girl with features compatible with Rett syndrome (RS) (Huttenlocher, 1991Go). The recent identification of the gene responsible for a large proportion of RS cases (Amir et al., 1999Go) now permits accurate diagnosis of this condition.


    Genetic Disorders with Definitive Dendritic Involvement: DS, RS, Fragile-X Syndrome
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
Most of the studies of dendritic pathology in syndromes associated with MR have focused on pyramidal neurons in the cerebral cortex. The most comprehensively examined genetic disorders are DS and RS. DS, the most common genetic condition associated with MR (Moser, 1995Go), is characterized by abnormal physical and neurologic growth. In addition to malformations involving mainly the heart and gastrointestinal tract, brain growth is delayed in DS. Brain size and weight are reduced at birth, gyral pattern is immature, neocortical laminar formation is irregular and myelination of cortical fibers is delayed (Kemper, 1988Go; Wisniewski, 1990Go; Golden and Hyman, 1994Go; Wisniewski and Kida, 1994Go). Several neocortical regions have been examined by Golgi impregnations and have revealed changes similar to those reported in unclassified MR. The initial study of an 18-month-old infant with DS by Marin-Padilla, the earliest to analyze dendritic spines in MR, demonstrated spines that were sparse, small and had short stalks in the motor cortex (Marin-Padilla, 1972Go). This dendritic spine abnormality contrasted with features displayed in a newborn with Patau syndrome (D, 13–15 trisomy), which demonstrated the typical elements of spine dysgenesis (Purpura, 1974Go), decreased density, and long and tortuous profile (Marin-Padilla, 1972Go, 1974Go) (see Figure 1Go). A later and more detailed follow-up study by Marin-Padilla (Marin-Padilla, 1976Go) showed that the spine changes in DS are not specific. Short spines were intermingled with the unusually long spines described by Purpura (Purpura, 1974Go). Interestingly, the spine dysgenesis was associated with dendritic vacuolation and neuronal necrosis, suggesting a degenerative process in DS (Marin-Padilla, 1976Go). At least three other investigations have examined dendritic spines in DS neocortex and hippocampus. Suetsugu and Mehraein (Suetsugu and Mehraein, 1980Go) counted spines in the cingulate cortex and hippocampus of seven DS subjects without Alzheimer disease (AD)-like pathology. They found that, compared with normal controls, spines were significantly reduced in the middle and distal segments of apical dendrites. That these findings in DS are specific is suggested by the fact that similar analyses in a group of individuals with unclassified MR did not show a decrease in dendritic spines (Suetsugu and Mehraein, 1980Go). The possibility that dendritic spine dysgenesis in DS represents an early postnatal degenerative process was raised by the study by Takashima and colleagues (Takashima et al., 1981Go), one of the largest studies in respect to sample size, which analyzed neurons of the visual cortex in fetuses, neonates and infants with DS. A decrease in dendritic spines was observed only in newborns and older subjects with DS (Takashima et al., 1981Go). Another study which supports the unique nature of spine pathology in DS is that of Ferrer and Gullotta (Ferrer and Gullotta, 1990Go). They examined CA1–CA3 pyramidal neurons of the hippocampus in two older patients with DS but without AD features. Spine counts were compared with normal controls and two DS subjects with associated AD pathology. The number of spines was reduced in all DS subjects, even though the changes were more severe in those DS individuals with AD particularly in CA1.

Dendritic length has also been evaluated in DS neocortex. In the previously cited study by Takashima and collaborators (Takashima et al., 1981Go), 14 fetuses and infants with DS were compared with normal age-matched controls. They found that shorter basilar dendrites were present only in those DS subjects who were older than 4 months. In a subsequent quantitative study of multiple dendritic branch parameters in eight infants and children with DS they showed that dendritic branching (measured as intersections using the Sholl's concentric circle) and length, in both apical and basilar dendrites, was greater than in controls in DS infants less than 6 months old (Becker et al., 1986Go). Subsequent to this age, there was a steady decrease in these measures to below normal in subjects older than 2 years. These changes seemed more dramatic in apical dendrites of layer III neurons (Becker et al., 1986Go). Additional cross-sectional studies have demonstrated marked reductions in dendritic branching, length and spine density in aged DS subjects (Takashima et al., 1989Go) [reviewed by Becker et al. (Becker et al., 1991Go)]. In these older individuals degenerative neuronal changes, such as those described by Marin-Padilla (Marin-Padilla, 1976Go), were also associated with dendritic abnormalities. In the last decade, these findings have been corroborated by two other reports on pyramidal (Schulz and Scholz, 1992Go) and non-pyramidal neurons (Prinz et al., 1997Go) from the parietal and motor cortices, respectively. Normal or increased branching in DS infants (Schulz and Scholz, 1992Go; Prinz et al., 1997Go) contrasts with reduced dendrites and degenerative changes in older DS children (Schulz and Scholz, 1992Go).

In contrast to DS, reductions in dendritic arborizations are present throughout life in RS (Armstrong et al., 1995Go). RS is a developmental disorder that affects females almost exclusively, with a large proportion of cases linked to mutations in the X chromosome gene MeCP2 (Amir et al., 1999Go). The latter codes for a transcriptional regulator protein, linked to transcriptional repression of methylated gene sequences (Stratling and Yu, 1999Go). MeCP2 mutations in RS would lead to altered functional domains of the protein (Amir et al., 1999Go; Wan et al., 1999Go). RS is characterized by an apparently normal perinatal period, followed by physical and neurological developmental arrest. Between ages 2 and 10 years (stages II and III) there is a regression of language and motor skills, seizures, and appearance of characteristic stereotypic movements. Severe neurologic impairment, including MR, stabilizes by late childhood (Naidu et al., 1995Go; Naidu, 1997Go). Initial neuroanatomic evaluations showed that cortical structure, including neuronal number and lamination, are relatively preserved in RS (Jellinger and Seitelberger, 1986Go; Jellinger et al., 1988Go). Cytoarchitectonic studies by Bauman and colleagues (Bauman et al., 1995Go) showed that while neuronal size is reduced there is an increase in neuronal cell packing density. Consistent with this increased neuronal packing, Armstrong and collaborators (Armstrong et al., 1995Go) demonstrated that basilar and, in some instances, apical branches of pyramidal cells from frontal, motor and inferior temporal cortices were significantly reduced when compared with normal controls. Relative preservation of posterior cortices is suggested by both volumetric neuroimaging (Reiss et al., 1993Go) and these post-mortem dendritic (Armstrong et al., 1995Go) studies. Basilar dendrites were more affected than apical ones, particularly in layer V neurons (Armstrong et al., 1995Go). A more recent investigation by the same group provided additional evidence for the specificity of the dendritic abnormalities in RS cerebral cortex. When compared with neurons from individuals with DS, dendritic arborizations from RS subjects showed the greatest reductions again in premotor, motor and inferior temporal cortices (Armstrong et al., 1998Go). These data underscore the severe nature of the dendritic tree disturbances in RS neocortex. Belichenko and collaborators (Belichenko et al., 1994Go), using the lipophilic dye labeling technique and confocal microscopy, were able to delineate the 3-D structure of dendrites from prefrontal, motor and middle temporal areas. They demonstrated that apical dendrites were asymmetric and reduced, and that dendritic spines were markedly decreased, with some segments devoid of these elements. Apparently these spine changes did not correspond to spine dysgenesis, since illustrations in this publication show rather short but otherwise unremarkable spines (Belichenko et al., 1994Go). Dendrites of hippocampal neurons have also been analyzed in RS. Armstrong et al. (Armstrong et al., 1995Go) showed reduced dendritic arborizations confined to neurons of layers II and IV of the subiculum, and none in CA1. These data are somewhat at variance with cytoarchitectonic evaluations that reported higher neuronal density throughout the pyramidal layer (including CA1) and, to a lesser extent, in the subiculum (Bauman et al., 1995Go).

Fragile-X syndrome (FraX) is the second most genetically determined form of MR [reviewed by Moser and Kaufmann and Reiss (Moser, 1995Go; Kaufmann and Reiss, 1999Go)]. Despite its high frequency, FraX has been studied less extensively with neuropathological techniques than DS or RS. Only two publications have addressed the issue of neuronal abnormalities. Hinton and colleagues (Hinton et al., 1991Go) extended the data on one subject previously reported by Rudelli et al. (Rudelli et al., 1985Go). Neocortical analyses of the three mildly to moderately mentally retarded adult FraX subjects showed that neuronal density in the posterior cingulate and anterior temporal regions was similar to controls. However, Golgi preparations showed long tortuous dendritic spines with prominent heads. The less than optimal quality of the Golgi impregnations precluded an analysis of the dendritic branch or spine density (Hinton et al., 1991Go). No subsequent studies have been reported in FraX subjects, although dendritic labeling by Golgi techniques has been applied to the mouse model of this condition, as described in a following section.


    Genetic Disorders with Probable Dendritic Involvement: Williams Syndrome, Rubinstein-Taybi Syndrome
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
Cytoarchitectonical techniques have helped to delineate cortical development in a large number of developmental disorders [reviewed by Kaufmann (Kaufmann, 1996Go)]. These approaches have been particularly helpful in conditions affecting neuronal proliferation and migration, in which disturbances in laminar organization and neuronal number typically occur [reviewed by Barth and Kaufmann and Galaburda (Barth, 1987Go; Kaufmann and Galaburda, 1989Go)]. Cytoarchitectonic studies have also shown aberrant cytodifferentiation in neuronal migration disorders, such as the presence of neurons of abnormal size and orientation [reviewed by Rorke and by Crino and Eberwine (Rorke, 1994Go; Crino and Eberwine, 1997Go)]. Similar findings have been reported by Logdberg and Brun (Logdberg and Brun, 1993Go) in unclassified MR. In addition to these parameters, quantitative cytoarchitectonics can provide information about neuronal cell body size and cell packing density. In RS, for instance, there is a reduction in neuronal soma size that is associated with an increase in cell packing density (Bauman et al., 1995Go). Similar features have been reported by the same investigators in the hippocampus and other limbic-related regions in autism (Bauman and Kemper, 1985Go) [reviewed by Kemper and Bauman (Kemper and Bauman, 1998Go)]. The significance of increased neuronal density has been underscored by parallel studies using the Golgi method that showed a correlation between cell packing and reduction in dendritic arborizations in these two conditions [discussed for RS (Raymond et al., 1996Go; Kaufmann et al., 1998Go) and for autism (Kemper and Bauman, 1998Go)]. These data support the concept that the finding of increased neuronal density by cytoarchitectonic analyses can be interpreted as signifying a likely reduction in length and complexity of dendritic trees.

Preliminary studies of cortical cytoarchitecture have been performed in two genetic disorders associated with MR: Williams syndrome (WS) and Rubinstein-Taybi syndrome (R-TS). WS is caused by a submicroscopic deletion on chromosome 7q11.23, which includes the elastin gene and the HPC-1/ syntaxin 1A (STX1A) gene that codes for a protein involved in the docking of synaptic vesicles [reviewed by Bellugi et al. and Botta et al. (Bellugi et al., 1999aGo; Botta et al., 1999Go)]. Patients with WS show a distinctive cognitive and social phenotype. While they demonstrate relatively preserved language and face processing abilities, they are typically impaired in visuospatial domains. In addition, they are hypersociable, with engaging personality and excessive sociability with strangers (Bellugi et al., 1999aGo,bGo). Neuropathological data on WS are limited to descriptions of associations with CNS malformations (Pober and Filiano, 1995Go) and AD-like changes (Golden et al., 1995Go). A single study of one patient by Galaburda and colleagues (Galaburda et al., 1994Go) reported several cytoarchitectonical anomalies, which included a reduction in columnar organization throughout the cortex, abnormal neuronal orientation and a generalized increase in cell packing density. These findings appeared to be more severe in posterior cortical regions, where there was a decrease in volume (Galaburda et al., 1994Go), as had previously been shown by quantitative neuroimaging (Jernigan et al., 1993Go). As the authors of both publications point out, this topographic distribution of severity of abnormalities is in general agreement with the WS cognitive phenotype. In conclusion, preliminary data indicate that in WS there is selective cortical hypoplasia associated with cytoarchitectonical features previously described in unclassified MR and DS (reduced laminar organization and abnormal neuronal orientation), and in autism and RS (increased neuronal cell packing density).

The second MR-related disorder in which cytoarchitectonics suggests dendritic abnormalities is R-TS. With an approximately similar incidence in the general population to RS (Moser, 1995Go), this condition is characterized by MR and a specific pattern of somatic abnormalities. The initial description by Rubinstein and Taybi (Rubinstein and Taybi, 1963Go) emphasized short stature, facial dysmorphia, broad thumbs and first toes, and MR. More recent work has demonstrated a wider spectrum of physical and neurologic abnormalities, which include deficits in expressive language and maladaptive behavior (Stevens et al., 1990Go). The genetic defect in R-TS (16p13.3) has been reported to involve cyclic AMP response element binding protein (CREB)-binding protein (CBP) (Petrij et al., 1995Go), a protein that is recruited by CREB to bind DNA and activates the basal transcription factor–enzyme complex (Kaufmann and Worley, 1999Go). Limited neuroimaging and neuropathologic investigations have shown an association between R-TS and several CNS malformations, such as agenesis of the corpus callosum (Stevens et al., 1990Go), Dandy-Walker malformation (Bonioli et al., 1989Go) and cortical clefts (Sener, 1995Go). The most comprehensive neuropathologic evaluation of a R-TS brain was carried out by Pogacar and collaborators (Pogacar et al., 1973Go). These authors reported one adult male case (33 years) with mild reduction in brain weight, preserved general cortical architecture, but decreased neuronal size and a marked increase (semi-quantitative) in cell packing density. As the latter findings closely resembled those reported in RS (Kaufmann et al., 1998Go), a reduction in dendritic arborizations appears also to be a feature of R-TS.

Two other relatively frequent genetic disorders, neurofibromatosis-1 and tuberous sclerosis (Bourneville disease, BD), usually present with mild MR or learning disorders (Harrison et al., 1999Go; Ozonoff, 1999Go), and display focal cytoarchitectonic abnormalities suggestive of dendritic pathology. Direct dendritic evaluations have been carried out only in BD. Cortical tubers, the hallmark lesion in BD, are foci of disrupted laminar cortical architecture containing large and disorganized cells. Ferrer and colleagues (Ferrer et al., 1984Go) and Machado-Salas (Machado-Salas, 1984Go) demonstrated that tubers consist of maloriented pyramidal neurons, with simplified structure and aberrant dendritic branches and spines. Moreover, large numbers of stellate neurons and astrocytes are also present in these clusters. Machado-Salas (Machado-Salas, 1984Go) even suggested neuronoglial formations with specialized contacts. Huttenlocher and Heydemann (Huttenlocher and Heydemann, 1984Go) confirmed most of these findings and examined the neocortex intervening between tubers. Despite its normal architecture and dendritic morphology, this adjacent cortex shows a decrease in dendritic branch length. These authors emphasized the similarity between these dendritic reductions and those found in several forms of MR. Table 1Go summarizes the dendritic and cytoarchitectonic abnormalities found in genetic disorders with definitive and probable dendritic involvement, respectively.


View this table:
[in this window]
[in a new window]
 
Table 1 Neocortical cytoarchitectonic and dendritic abnormalities in genetic disorders associated with MRa
 

    Dendritic Abnormalities and Cognitive Profile
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
Proof of dendritic pathology as a distinctive feature and substrate of MR requires the demonstration of its consistency across multiple conditions associated with MR. The data reviewed above suggest that either reductions in dendritic branch complexity or length or changes in dendritic spines are consistent features in genetic MR. More limited information is available about non-genetic causes of MR; nevertheless, a few studies demonstrate cytoarchitectonic and dendritic abnormalities similar to those in genetic disorders [reviewed by DeLong (DeLong, 1993Go)]. Two investigations have shown reduction in dendritic arborizations (Cordero et al., 1993Go; Benitez-Bribiesca et al., 1999Go) and spine dysgenesis (Benitez-Bribiesca et al., 1999Go), in moderate to severe protein-calorie malnutrition. Iodine deficiency leads to MR, deaf-mutism and muscle hypertonia, in addition to the somatic changes associated with cretinism (DeLong, 1993Go). Neuropathological evaluations have shown that, in addition to moderate brain weight decreases, there is a reduction in neuronal density and aberrant neuronal orientation, and a decrease in dendritic branching involving both pyramidal and non-pyramidal neurons (DeLong, 1993Go; Yan et al., 1989Go). Studies of fetuses from iodine-deficient mothers do not display such abnormalities (Liu et al., 1989Go), suggesting that late phases of neuronal development, particularly differentiation, are affected most.

Are dendritic abnormalities a specific feature of MR? Huttenlocher (Huttenlocher, 1991Go) and others (Williams et al., 1978Go) in their studies of dendrites have emphasized the existence of confounding variables, such as cardiac malformations in chromosopathies. Even after these factors are taken into account, the description of similar changes in several metabolic disorders that affect primarily the cerebral cortex and present with a degenerative-dementing course (Della Giustina, et al., 1981Go; Takashima et al., 1985Go) support the concept that marked dendritic abnormalities are an index of major neuronal disruption. However, there are some differences between the findings in metabolic-degenerative disorders and those of genetic MR. First, neuronal migration defect or severe lamination disturbance are relatively common in the progressive metabolic disorders (Barth, 1987Go) but absent in the non-progressive genetic disorders such as DS. Second, in many metabolic disorders there is accumulation of storage material in neuronal somata and proximal dendrites and axons that leads to distinctive Golgi impregnation patterns (Williams et al., 1977Go; Purpura, 1978Go; Takashima et al., 1985Go). The dendritic aberrations in storage disorders such as gangliosidoses and neuronal ceroid lipofuscinoses are associated with abnormalities of the axon and the presynaptic domain, and include anomalous spatial configuration of cortical neurons (Purpura and Suzuki, 1976Go). Phenylketonuria (PKU) shows a yet different pattern. This aminoacidopathy, which leads to MR when untreated, has been characterized from the neuropathologic standpoint to be associated with changes in the white matter. There is no storage. However, Bauman and Kemper (Bauman and Kemper, 1982Go) with the aid of Golgi techniques have shown that gray matter pathology, particularly dendritic changes, is even more pronounced than that in the white matter. They found reductions in dendritic arborizations and spine dysgenesis that were similar to those reported in unclassified MR and DS. It appears therefore that metabolic-degenerative disorders show qualitative and quantitative alterations of dendritic morphology that correlate with cognitive impairment as in MR. However, these changes are dynamic and share with MR only the diffuse and severe magnitude of the dendritic pathology (Kaufmann, 1992Go).

If severe dendritic changes are a reflection of generalized cortical dysfunction, milder cognitive impairment should be associated with milder dendritic abnormalities. Two studies have partially addressed this issue. The first compared cortical areas with significant dendritic reductions in RS, in which there is profound cognitive impairment, with comparable samples from DS patients. All three premotor, motor and visual cortices in RS had reduced dendritic length compared with DS, with the greatest reductions affecting the frontal regions (Armstrong et al., 1998Go). As cognitive impairment is, in general, greater in RS than DS, these comparisons suggest a direct relationship between dendritic pathology and cognitive deficit. A more direct assessment was carried out by Yan et al. (Yan et al., 1989Go), who demonstrated a parallel between dendritic decreases and degree of MR in adult cretinism. Unfortunately, virtually no data about dendritic anomalies are available in individuals with learning disabilities. If severity and extent of dendritic pathology correlates with cognitive function, it is expected that learning disabled subjects would show mild dendritic abnormalities. In support of this hypothesis are the findings in three cases with FraX, with IQ in the 40–60 range. Hinton and collaborators (Hinton et al., 1991Go) reported the presence of dendritic spine abnormalities without cytoarchitectonic changes.

If dendritic abnormalities are a signature of global cognitive dysfunction, do they play a role in the selective cognitive deficits observed in many syndromes associated with MR? Neuropathologic and neuroimaging studies have already shown some correlations between cortical regional volume and specific impairment. For instance, in DS there is a reduction in temporal and frontal lobe volumes that, in general terms, is in agreement with the selective impairment in language in these patients (Kemper, 1988Go; Jernigan et al. 1993Go). Similar associations have been demonstrated for visuospatial impairment and parietooccipital volumes in WS (Jernigan et al., 1993Go). These topographical surveys, which require the evaluation of a large number of cortical regions, can be correlated with neuroimaging approaches, particularly when large blocks of cortex are measured. A more difficult task is the quantitative or semiquantitative study of cytoarchitectonics or Golgi-based dendritic evaluations of multiple cortical areas. To our knowledge, complete qualitative cytoarchitectonic surveys have only been reported for DS [multiple subjects (Kemper, 1988Go)], RS [three patients (Bauman et al., 1995Go)] and WS [one individual (Galaburda et al., 1994Go)]. Only the latter study attempted to relate pattern of cortical structure and cognitive profile, and no cytoarchitectonic investigation has yet reported measures of multiple cortical regions. In terms of dendritic arborizations, a single study of RS evaluated several cortical regions and neuronal populations within each area (Armstrong et al., 1995Go). Areas related to preparation (area 6, frontal premotor) and execution (area 4, frontal motor) of movements were affected in RS, whereas the occipital visual cortex (area 17) was relatively preserved. These findings are consistent with the RS phenotype, in which there is severe motor impairment (hypotonia, poor hand use, stereotypic movements, gait disturbances) with relative sparing of visual function (Naidu, 1997Go). A follow-up study confirmed and expanded the initial observations, but also showed preservation of the superior temporal cortex (Armstrong et al., 1998Go), a region involved in language processing. As language delay and regression are typical features of RS (Naidu, 1997Go), these later studies do not support the postulate that dendritic abnormalities reflect cortical dysfunction. More studies are needed to evaluate the relationship between dendritic abnormalities and cognitive profile in MR.

Another critical feature shown by several MR-associated disorders is the diminished maturational increment of cognition and sometimes-frank decline. This has been evaluated from the dendritic viewpoint in three of the main genetic syndromes: DS (Hayes and Batshaw, 1993Go), RS (Naidu, 1997Go) and FraX (Fisch et al., 1999aGo). Studies of DS have suggested dendritic changes as a basis for cognitive decline, but there is as yet no evidence for such a relationship for the other two disorders. In cross-sectional analyses of dendritic growth (length) in DS (Takashima et al., 1981Go; Becker et al., 1986Go), dendritic arborizations appeared to be overproduced initially, with a tendency to regress towards the end of the first year, a temporal pattern that parallels cognitive evaluations. In contrast, Armstrong and collaborators (Armstrong et al., 1995Go) did not find a relationship between dendritic length and age. It should be noted, however, that their regression analyses covered a wide age range (2.9–35 years), which could have masked the declining phase of cognition that occurs between ages 2 and 10 years.


    Dendritic Abnormalities and Synaptic Circuitry and MR
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
The most obvious mechanism by which dendritic pathology in general, and reductions in dendritic arborizations in particular, could lead to neurologic impairment is a decrease in the cortical postsynaptic surface. The latter should correlate with a reduction in synaptic density, while spine dysgenesis may represent a preferential reduction in excitatory synapses. These assumptions have not yet been tested rigorously in genetic MR. To date no study has compared dendritic labeling and synapse analysis in MR, although some subjects have been independently examined by one or the other approach. Electron microscopic (EM) studies have been confined almost exclusively to DS, and with contradictory results. There are reports of both decreased (Wisniewski et al., 1985Go) and increased (Cragg, 1975Go) synaptic density as well as of arrest in synaptic development (increased primitive synaptic contacts) (Petit et al., 1984Go). Only a preliminary analysis by P.R. Huttenlocher (personal communication) found reduced synaptic density in the prefrontal cortex in RS. What are the factors causing these discrepancies? They could be related to the quality of the Golgi staining; long post-mortem interval, agonal changes and aldehyde fixation interfere with adequate dendritic impregnation (Williams et al., 1978Go; Buell, 1982Go). Hinton and colleagues (Hinton et al., 1991Go), in their study of FraX neocortex, stated that ‘Golgi analysis was less than optimal because of incomplete dendritic stain impregnation’, and observations about dendritic spine morphology are the only reliable data obtained in this investigation (Hinton et al., 1991Go). In his review, Huttenlocher (Huttenlocher, 1991Go) emphasized age as an important factor. While dendritic labeling has been performed in young subjects, synaptic counts have involved older individuals. This is of particular significance, since some studies suggest catch-up dendritic growth in unclassified MR (Williams et al., 1980Go). The potential of correlating EM and Golgi studies is suggested by Kaufmann et al. (Kaufmann et al., 1995Go, 1997aGo,bGo), who demonstrated in RS a parallel between dendritic protein immunoreactivity, by immunoblotting and immunocytochemistry (Figure 2Go), and dendritic evaluations by Golgi (Armstrong et al., 1995Go, 1998Go). Similar ‘validation’ of dendritic abnormalities (Kaufmann, 1992Go) has been carried out in HIV encephalopathy (Masliah et al., 1997Go). Moreover, in RS dye labeling has also corroborated findings by Golgi impregnations (Belichenko et al., 1994Go). These data suggest that combined dendritic labeling–EM studies will aid the evaluation of the impact of dendritic changes in MR.



View larger version (117K):
[in this window]
[in a new window]
 
Figure 2.  MAP-2 immunoreactivity in RS. The marked reduction in MAP-2 immunostaining in somatosensory cortex is also seen, with variable intensity, in other neocortical regions. (A) MAP-2 immunostaining of somas and, predominantly, dendrites in a control subject. (B) An equivalent section from an RS patient displays smaller neuronal somas and few MAP-2 immunoreactive dendrites (arrowheads). Reprinted with permission (Kaufmann et al., 1998Go).

 

    Animal Models of MR and Dendritic Pathology
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
Study of dendritic abnormalities in animal models of MR minimizes confounding technical factors and permits evaluation of developmental patterns. There is an extensive literature on dendritic morphology and development in animal models relevant to MR [see the respective section in the review by Huttenlocher (Huttenlocher, 1991Go)]. Nonetheless, the validity of the animal models must be examined with care. Considerable efforts have been made in generating trisomic mice that model DS. Limited postnatal viability (Haydar et al., 1996Go) and incomplete characterizations (Holtzman et al., 1996Go) have precluded direct dendritic evaluations of these DS models. Other problems include unexpectedly mild behavioral phenotype, such as in the FraX mouse model (Fisch et al., 1999bGo). This FMR1 knockout mouse does, however, show spine dysgenesis (Comery et al., 1997Go) that closely resembles that reported by Hinton and colleagues (Hinton et al., 1991Go). Some experimental models of several non-genetic causes of MR have succeeded in reproducing the neuropathological and behavioral features of the human disorder. Examples of these are PKU (Nigam and Labar, 1979Go), protein-calorie malnutrition (Adaro et al., 1986Go; Diaz-Cintra et al., 1990Go), hypothyroidism (Ipina and Ruiz-Marcos, 1986Go; Nunez et al., 1992Go) and fetal alcohol exposure (Hannigan and Berman, 2000Go). These experimental paradigms are important because they help overcome the limitations of human studies due to small samples (e.g. PKU and cretinism) and suboptimal tissue processing (e.g. FraX). Even more significantly, they provide information about the dynamics of the process and potential remediation. For instance, the study by Lacey (Lacey, 1985Go) showed that dendritic spine maturational delay and increased spine density can be reversed by metabolic correction in PKU. On the other hand, Diaz-Cintra and collaborators (Diaz-Cintra et al., 1994Go) found that dendritic disturbances caused by prenatal malnutrition (as in placental insufficiency) in the rat are not reversed by postnatal nutritional rehabilitation. These approaches are critically important for the field of genetic MR, since gene-based and other therapies are beginning to be tested. If dendritic abnormalities are the cause of MR, they should be evaluated as outcome measures in experimental treatments. An example is the positive influence of environmental stimulation on cognitive development of children with DS (Ludlow and Allen, 1979Go). The morphological effects of sensory enrichment in rodent models have reported by Greenough (Greenough, 1984Go) and ourselves (Adaro et al., 1986Go) (Figure 3Go). These studies demonstrate that environmental stimulation leads to increases in length and complexity of dendritic arborizations in several cortical regions, even in adult life.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 3.  Dendritic anomalies in a model of MR. Camera lucida drawings of parietal cortex pyramidal neurons from juvenile (postnatal day 18) Sprague–Dawley rats. (A) Cells from animals that were deprived nutritionally and in terms of sensory stimulation, by changes in litter size. (B) The control situation. (C) Rats that were relatively enriched. Note the marked reduction in number and length of dendrites in deprived animals and the increased complexity of dendritic trees in enriched rats. Scale bar = 25 µm. The experimental paradigm is explained in detail elsewhere (Adaro et al., 1986Go). Reprinted with permission (Kaufmann et al., 1994Go).

 

    From Genotype to Dendritic Phenotype
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
Dendritic development is a sequential process in which generation, elongation, and retraction of dendritic branches and spines are the result of the interaction between intrinsic genetic programs and external modulators (e.g. neurotransmitters) [reviewed by Kaufmann (Kaufmann, 1999Go)]. Each morphologic stage is characterized by the expression of a set of dendritic proteins (Petit et al., 1988Go; Kaufmann et al., 1997aGo). For instance, early neuronal differentiation (extension of primary branches) is associated with the expression of the immature form of microtubule-associated protein 2 (MAP-2), also termed MAP-2c, and of MAP-5. Dendritic branching and terminal growth is linked to the adult form of MAP-2 (MAP-2a/b), whereas late phases such as dendritic modeling are associated with high levels of the high-molecular-weight form of nonphosphorylated neurofilaments (see Figure 4Go) (Kaufmann et al., 1997aGo). The role of neurotransmitters and growth factors in the progression of dendritic development is beginning to be disclosed (Figure 4Go). While acetylcholine seems to affect the dendritic expansion (Hohmann et al., 1991Go), activation of some subtypes of glutamate receptors is linked to dendritic pruning (Kaufmann, 1999Go). On the other hand, neurotrophins modulate dendritic arborizations in a layer-specific manner (McAllister et al., 1997Go).



View larger version (27K):
[in this window]
[in a new window]
 
Figure 4.  Diagrammatic representation of dendritic development. Dendritic formation includes three distinctive stages, characterized by morphological and molecular features: early dendritic differentiation, dendritic expansion or growth, and dendritic remodeling and pruning. Several modulators that are displayed between parentheses have been identified to influence this process. In humans, a substantial portion of dendritic development occurs postnatally.

 
We postulate that the genetic defect in MR associated with dendritic pathology disrupts signaling pathways and/or modulators of dendritic development. The three genetic MR syndromes in which single gene defects have been identified, FraX [reviewed by Kaufmann and Reiss (Kaufmann and Reiss, 1999Go)], RS (Amir et al., 1999Go) and R-TS (Petrij et al., 1995Go), share a defect in the regulation of gene expression. MeCP2 and CBP are involved in transcriptional regulation while fragile-X mental retardation protein (FMRP) modulates protein synthesis. The targets of these proteins are still unknown; however, they most likely influence the expression of regulatory proteins in signaling pathways rather than of components of dendrites directly. Preliminary analyses of transcripts potentially targeted by FMRP reveal that synthesis of MAP-2 in dendrites appears not be affected by the FMRP deficit (Steward et al., 1998Go). While it has been shown that FMRP binds transcripts of itself as well as of other FMRP homologues, no evidence of binding to transcripts of cytoskeletal or other structural proteins has been presented (Ceman et al., 1999Go). The large number of genes potentially regulated by either MeCP2 (Coy et al., 1999Go) or CBP (Bading, 1999Go) suggests a complex mechanism analogous to the one we proposed for early genes (Kaufmann and Worley, 1999Go). In the latter, we postulated that early genes that regulate transcription have a ‘double effect’ by influencing the expression of target (e.g. structural protein) and regulatory genes (e.g. transcription factor). Despite the large number of potential targets, we hypothesize that FMRP, MeCP2 and CBP will ultimately affect common signaling pathways. In ‘convergence’ points, we postulate there are proteins that are essential for neuronal differentiation and maintenance, such as kinases and the exclusively neuronal transcription factor NeuN. These ‘secondary’ genes may then modulate the quality and quantity of dendritic proteins, manifested morphologically as dendritic branch and spine structure. Figure 5Go depicts this model of dendritic formation and maintenance. Dendritic ‘regression’ in DS may be the consequence of a different mechanism. Among the genes overexpressed in trisomy 21 is the one coding for ß amyloid protein. Amyloid deposition in the form of the Aß peptide has been detected as early as at 21 gestational weeks in DS (Teller et al., 1996Go), which coincides with initial cortical dendritic growth (Huttenlocher, 1999Go). Inflammatory responses associated with Aß deposition in senile plaques in Alzheimer disease include production of cytokines (Dickson, 1997Go), which may operate as negative modulators of dendritic growth and maintenance in DS.



View larger version (34K):
[in this window]
[in a new window]
 
Figure 5.  Hypothetical genotype–dendritic phenotype pathway. We postulate that a primary genetic defect will lead to changes in the expression of proteins that play a critical role in dendritic protein expression. Thus several mutations can converge at nodal points of signaling pathways that regulate the levels and conformation of key dendritic constituents. These changes in dendritic proteins will, in turn, have a spectrum of phenotypic features ranging from anatomical to behavioral. The diagram exemplifies two single gene disorders, RS and FraX, and proposes potential secondary gene targets. Most of the data supporting this model come from immunochemical studies carried out in RS (Kaufmann et al., 1995Go, 1997aGo, bGo). Identification of critical points in dendritic signaling pathways may help in designing specific therapies for these MR-associated disorders. Abbreviations: NT, neurotransmitter; GF, growth factor.

 
The identification of common (nodal) points in ‘dendritic’ cell signaling pathways may be of great importance, since the regulation of these proteins by neurotransmitters and growth factors provides the opportunity for therapeutic intervention. Identification of the nature and timing of negative modulators of dendritic growth opens the possibility of preventing deleterious processes. The protracted dendritic development that characterizes the human cortex provides the opportunity for modifying its course, and the potential for interrupting or reversing abnormal synaptic development.


    Concluding Comments
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
Dendritic abnormalities are associated with many forms of MR, and may be the only evident pathology in some of these disorders. On the other hand, evaluations of presynaptic elements in MR have not yet been carried out. More systematic studies of both preand postsynaptic components in multiple cortical regions, at different stages, are still needed to determine the impact of dendritic abnormalities on synaptic structure and function. As it has been demonstrated for neurodegenerative disorders, establishment of genotype to phenotype molecular pathways, as well as validation of putative animal models, depend on accurate characterizations of neuropathologic features (Borchelt et al., 1998Go). Recent advances in developmental neurobiology and genetics of MR raise the possibility of more specific therapies for these disorders. A better characterization and understanding of dendritic abnormalities in MR will increase our capacity to accomplish this goal.


    Notes
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
Supported in part by NIH grants HD 24448, NS 35359 and HD 24061, and grant IIRG-99-1608 from the Alzheimer's Association.

Address correspondence to Walter E. Kaufmann, MD, Department of Developmental Cognitive Neurology, Kennedy Krieger Institute, Room 522, 707 N. Broadway, Baltimore, MD 21205, USA. Email: wekaufma{at}jhmi.edu.


    References
 Top
 Abstract
 Introduction
 Dendritic Spine Dysgenesis and...
 Genetic Disorders with...
 Genetic Disorders with Probable...
 Dendritic Abnormalities and...
 Dendritic Abnormalities and...
 Animal Models of MR...
 From Genotype to Dendritic...
 Concluding Comments
 Notes
 References
 
Adaro L, Fernández V, Kaufmann W (1986) Effects of nutritional– environmental interactions upon body weight, body size and development of cortical pyramids. Nutr Rep Int 33: 1013–1020.[ISI]

Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet 23:185–188.[ISI][Medline]

Armstrong D, Dunn JK, Antalffy B, Trivedi R (1995) Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 54:195–201.[ISI][Medline]

Armstrong DD, Dunn K, Antalffy B (1998) Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J Neuropathol Exp Neurol 57:1013–1017.[ISI][Medline]

Bading H (1999) Nuclear calcium-activated gene expression: possible roles in neuronal plasticity and epileptogenesis. Epilepsy Res 36: 225–231.[ISI][Medline]

Barth PG (1987) Disorders of neuronal migration. Can J Neurol Sci 14: 1–16.[ISI][Medline]

Batshaw ML (1993) Mental retardation. Pediatr Clin North Am 40: 507–521.[ISI][Medline]

Bauman ML, Kemper TL (1982) Morphologic and histoanatomic observations of the brain in untreated phenylketonuria. Acta Neuropathol (Berl) 58:55–63.[ISI][Medline]

Bauman M, Kemper TL (1985) Histoanatomic observations of the brain in early infantile autism. Neurology 35:866–874.[Abstract]

Bauman ML, Kemper TL, Arin DM (1995) Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 45:1581–1586.[Abstract]

Becker LE, Armstrong DL, Chan F (1986) Dendritic atrophy in children with Down's syndrome. Ann Neurol 20:520–526.[ISI][Medline]

Becker L, Mito T, Takashima S, Onodera K (1991) Growth and development of the brain in Down syndrome. Prog Clin Biol Res 373:133–152.[Medline]

Belichenko PV, Oldfors A, Hagberg B, Dahlström A (1994) Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. NeuroReport 5:1509–1513.[ISI][Medline]

Bellugi U, Lichtenberger L, Mills D, Galaburda A, Korenberg JR (1999a) Bridging cognition, the brain and molecular genetics: evidence from Williams syndrome. Trends Neurosci 22:197–207.[ISI][Medline]

Bellugi U, Adolphs R, Cassady C, Chiles M (1999b) Towards the neural basis for hypersociability in a genetic syndrome. NeuroReport 10: 1653–1657.[ISI][Medline]

Benitez-Bribiesca L, De la Rosa-Alvarez I, Mansilla-Olivares A (1999) Dendritic spine pathology in infants with severe protein-calorie malnutrition. Pediatrics 104:e21.[Medline]

Bodick N, Stevens JK, Sasaki S, Purpura DP (1982) Microtubular disarray in cortical dendrites and neurobehavioral failure. II. Computer reconstruction of perturbed microtubular arrays. Brain Res 281:299–309.[Medline]

Bonioli E, Bellini C, Di Stefano A (1989) Unusual association: Dandy-Walker-like malformation in the Rubinstein-Taybi syndrome. Am J Med Genet 33:420–421.[ISI][Medline]

Borchelt DR, Wong PC, Sisodia SS, Price DL (1998) Transgenic mouse models of Alzheimer's disease and amyotrophic lateral sclerosis. Brain Pathol 8:735–757.[ISI][Medline]

Botta A, Sangiuolo F, Calza L, Giardino L, Potenza S, Novelli G, Dallapiccola B (1999) Expression analysis and protein localization of the human HPC-1/Syntaxin 1A, a gene deleted in Williams syndrome. Genomics 62:525–528.[ISI][Medline]

Buell SJ (1982) Golgi–Cox and rapid Golgi methods as applied to autopsied human brain tissue: widely disparate results. J Neuropathol Exp Neurol 41:500–507.[ISI][Medline]

Ceman S, Brown V, Warren ST (1999) Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol Cell Biol 19:7925–7932.[Abstract/Free Full Text]

Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, Greenough WT (1997) Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 94:5401–5404.[Abstract/Free Full Text]

Cordero ME, D'Acuna E, Benveniste S, Prado R, Nunez JA, Colombo M (1993) Dendritic development in neocortex of infants with early postnatal life undernutrition. Pediatr Neurol 9:457–464.[ISI][Medline]

Coy JF, Sedlacek Z, Bachner D, Delius H, Poustka A (1999) A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3'-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum Mol Genet 8:1253–1262.[Abstract/Free Full Text]

Cragg BG (1975) The density of synapses and neurons in normal, mentally defective and aging human brains. Brain 98:81–90.[ISI][Medline]

Crino PB, Eberwine J (1997) Cellular and molecular basis of cerebral dysgenesis. J Neurosci Res 50:907–916.[ISI][Medline]

Crome L, Stern J (1972) Pathology of mental retardation. Edinburgh: Churchill Livingstone.

Crosby EC, Humphrey T, Lauer EW (1962) Correlative anatomy of the nervous system. New York: Macmillan.

Della Giustina E, Goffinet AM, Landrieu P (1981) A Golgi study of the brain malformation in Zellweger's cerebro-hepato-renal disease. Acta Neuropathol (Berl) 55:23–28.[ISI][Medline]

DeLong GR (1993) Effects of nutrition on brain development in humans. Am J Clin Nutr 57(2 Suppl):286S–290S.[Abstract]

Diaz-Cintra S, Cintra L, Ortega A, Kemper T, Morgane PJ (1990) Effects of protein deprivation on pyramidal cells of the visual cortex in rats of three age groups. J Comp Neurol 292:117–126.[ISI][Medline]

Diaz-Cintra S, Garcia-Ruiz M, Corkidi G, Cintra L (1994) Effects of prenatal malnutrition and postnatal nutritional rehabilitation on CA3 hippocampal pyramidal cells in rats of four ages. Brain Res 662:117–126.[ISI][Medline]

Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56:321–339.[ISI][Medline]

Ferrer I, Gullotta F (1990) Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus. Acta Neuropathol (Berl) 79:680–685.[ISI][Medline]

Ferrer I, Fabregues I, Coll J, Ribalta T, Rives A (1984) Tuberous sclerosis: a Golgi study of cortical tuber. Clin Neuropathol 3:47–51.[ISI][Medline]

Fisch GS, Carpenter N, Holden JJ, Howard-Peebles PN, Maddalena A, Borghgraef M, Steyaert J, Fryns JP (1999a) Longitudinal changes in cognitive and adaptive behavior in fragile X females: a prospective multicenter analysis. Am J Med Genet 83:308–312.[ISI][Medline]

Fisch GS, Hao HK, Bakker C, Oostra BA (1999b) Learning and memory in the FMR1 knockout mouse. Am J Med Genet 84:277–282.[ISI][Medline]

Freytag E, Lindenberg R (1967) Neuropathologic findings in patients of a hospital for the mentally deficient. A survey of 359 cases. Johns Hopkins Med J 121:379–392.[ISI][Medline]

Galaburda AM, Wang PP, Bellugi U, Rossen M (1994) Cytoarchitectonic anomalies in a genetically based disorder: Williams syndrome. Neuro-Report 5:753–757.[ISI][Medline]

Golden JA, Hyman BT (1994) Development of the superior temporal neocortex is anomalous in trisomy 21. J Neuropathol Exp Neurol 53:513–520.[ISI][Medline]

Golden JA, Nielsen GP, Pober BR, Hyman BT (1995) The neuropathology of Williams syndrome. Report of a 35-year-old man with presenile beta/A4 amyloid plaques and neurofibrillary tangles. Arch Neurol 52:209–212.[Abstract]

Greenough WT (1984) Structural correlates of information storage in the mammalian brain: a review and hypothesis. Trends Neurosci 7: 229–233.[ISI]

Hannigan JH, Berman RF (2000) Amelioration of fetal alcohol-related neurodevelopmental disorders in rats: exploring pharmacological and environmental treatments. Neurotoxicol Teratol 22:103–111.[ISI][Medline]

Harrison JE, O'Callaghan FJ, Hancock E, Osborne JP, Bolton PF (1999) Cognitive deficits in normally intelligent patients with tuberous sclerosis. Am J Med Genet 88:642–646.[ISI][Medline]

Haydar TF, Blue ME, Molliver ME, Krueger BK, Yarowsky PJ (1996) Consequences of trisomy 16 for mouse brain development: corticogenesis in a model of Down syndrome. J Neurosci 16: 6175–6182.[Abstract/Free Full Text]

Hayes A, Batshaw ML (1993) Down syndrome. Pediatr Clin North Am 40:523–535.[ISI][Medline]

Hinton VJ, Brown WT, Wisniewski K, Rudelli RD (1991) Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet 41:289–294.[ISI][Medline]

Hohmann CF, Kwiterovich KK, Oster-Granite ML, Coyle JT (1991) Newborn basal forebrain lesions disrupt cortical cytodifferentiation as visualized by rapid Golgi staining. Cereb Cortex 1:143–157.[Abstract]

Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE, Johnson RM, Chen K, Sun Y, Carlson E, Alleva E, Epstein CJ, Mobley WC (1996) Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci USA 93:13333–13338.[Abstract/Free Full Text]

Hornykiewicz O (1963) Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamin (3-Hydroxytyramin) in der Sustantia Nigra des normalen und Parkinson kranken Meschen. Wien Klin Wochenschr 75:309–312.

Huttenlocher PR (1970) Dendritic development and mental defect. Neurology 20:381.

Huttenlocher PR (1974) Dendritic development in neocortex of children with mental defect and infantile spasms. Neurology 24:203–210.[ISI][Medline]

Huttenlocher PR (1991) Dendritic and synaptic pathology in mental retardation. Pediat Neurol 7:79–85.[ISI][Medline]

Huttenlocher PR (1999) Dendritic and synaptic development in human cerebral cortex: time course and critical periods. Devl Neuropsychol 16:347–349.[ISI]

Huttenlocher PR, Heydemann PT (1984) Fine structure of cortical tubers in tuberous sclerosis: a Golgi study. Ann Neurol 16:595–602.[ISI][Medline]

Ipina SL, Ruiz-Marcos A (1986) Dendritic structure alterations induced by hypothyroidism in pyramidal neurons of the rat visual cortex. Brain Res 394:61–67.[Medline]

Jellinger K (1972) Neuropathological features of unclassified mental retardation. In: The brain in unclassified mental retardation (Cavanagh JB, ed.), pp. 293–306. London: Churchill Livingstone.

Jellinger K, Seitelberger F (1986) Neuropathology of Rett syndrome. Am J Med Genet Suppl 1:259–288.[Medline]

Jellinger K, Armstrong D, Zoghbi HY, Percy AK (1988) Neuropathology of Rett syndrome. Acta Neuropathol (Berl) 76:142–158.[ISI][Medline]

Jernigan TL, Bellugi U, Sowell E, Doherty S, Hesselink JR (1993) Cerebral morphologic distinctions between Williams and Down syndromes. Arch Neurol 50:186–191.[Abstract]

Kaufmann WE (1992) Editorial. Cerebrocortical changes in AIDS. Lab Invest 66:261–264.[ISI][Medline]

Kaufmann WE (1996) Mental retardation and learning disabilities: a neuropathologic differentiation. In: Developmental disabilities in infancy and childhood (Capute AJ, Accardo PJ, eds), vol. 2, pp. 49–70. Baltimore, MD: Paul H. Brookes Publishing.

Kaufmann WE (1999) Cytoskeletal determinants of dendritic development and function: implications for mental retardation. Devl Neuropsychol 16:341–346.[ISI]

Kaufmann WE, Galaburda AM (1989) Cerebrocortical microdysgenesis in neurologically normal subjects: a histopathologic study. Neurology 39:238–244.[Abstract]

Kaufmann WE, Reiss AL (1999) Molecular and cellular genetics of Fragile X syndrome. Am J Med Genet (Neuropsychol Genet) 88:11–24.

Kaufmann WE, Worley PF (1999) The role of early neural activity in regulating immediate early gene expression in the cerebral cortex. MRDD Res Rev 5:41–50.

Kaufmann WE, Yamagata K, Andreasson KI, Worley PF (1994) Rapid response genes as markers of cellular signaling during cortical histogenesis: their potential in understanding mental retardation. Int J Devl Neurosci 12:263–271.[ISI][Medline]

Kaufmann WE, Naidu S, Budden S (1995) Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome. Neuropediatrics 26:109–113.[ISI][Medline]

Kaufmann WE, Worley PF, Taylor CV, Bremer M, Isakson PC (1997a) Cyclooxygenase 2 expression during rat neocortical development and in Rett syndrome. Brain Dev 19:25–34.[ISI][Medline]

Kaufmann WE, Taylor CV, Hohmann CF, Sanwal IB, Naidu S (1997b) Abnormalities in neuronal maturation in Rett syndrome neocortex: preliminary molecular correlates. Eur Child Adolesc Psychiat 6(Suppl 1):75–77.[ISI][Medline]

Kaufmann WE, Pearlson GD, Naidu S (1998) The neuroanatomy of Rett syndrome: neuropathological and neuroimaging studies. Riv Med 4:187–199.

Kemper TL (1988) Neuropathology of Down syndrome. In: The psychobiology of Down syndrome (Nadel L, ed.), pp. 269–289. Cambridge, MA: MIT Press.

Kemper TL, Bauman M (1998) Neuropathology of infantile autism. J Neuropathol Exp Neurol 57:645–652.[ISI][Medline]

Lacey DJ (1985) Normalization of dendritic spine numbers in rat hippocampus after termination of phenylacetate injections (PKU model). Brain Res 329:354–355.[ISI][Medline]

Liu J, Tan Y, Zhuang Z, Shi Z, Chen B, Zhang J (1989) Influence of iodine deficiency on human fetal thyroid gland and brain. In: Iodine and the brain (DeLong GR, Robbins J, Condliffe PG, eds), pp. 249–258. New York: Plenum.

Logdberg B, Brun A (1993) Prefrontal neocortical disturbances in mental retardation. J Intellect Disabil Res 37:459–468.[ISI][Medline]

Ludlow JR, Allen LM (1979) The effect of early intervention and pre-school stimulus on the development of the Down's syndrome child. J Ment Defic Res 23:29–44.[ISI][Medline]

Machado-Salas JP (1984) Abnormal dendritic patterns and aberrant spine development in Bourneville's disease—a Golgi survey. Clin Neuropathol 3:52–58.[ISI][Medline]

Marin-Padilla M (1972) Structural abnormalities of the cerebral cortex in human chromosomal aberrations. A Golgi study. Brain Res 44: 625–629.[ISI][Medline]

Marin-Padilla M (1974) Structural organization of the cerebral cortex (motor area) in human chromosomal aberrations. A Golgi study. I. D1 (13–15) trisomy, Patau syndrome. Brain Res 66:373–391.

Marin-Padilla M (1976) Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome: a Golgi study. J Comp Neurol 167: 63–82.[ISI][Medline]

Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42:963–972.[ISI][Medline]

McAllister AK, Katz LC, Lo DC (1997) Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron 18: 767–778.[ISI][Medline]

Moser HW (1995) A role for gene therapy in mental retardation. MRDD Res Rev 1:4–6.

Naidu S, Hyman S, Harris EL, Narayanan V, Johns D, Castora F (1995) Rett syndrome studies of natural history and search for a genetic marker. Neuropediatrics 26:63–66.[ISI][Medline]

Naidu S (1997) Rett syndrome: a disorder affecting early brain growth. Ann Neurol 42:3–10.[ISI][Medline]

Nigam MP, Labar DR (1979) The effect of hyperphenylalaninemia on size and density of synapses in rat neocortex. Brain Res 179:195–198.[ISI][Medline]

Nunez J, Couchie D, Aniello F, Bridoux AM (1992) Thyroid hormone effects on neuronal differentiation during brain development. Acta Med Aust 19(Suppl 1):36–39.[ISI][Medline]

Ozonoff S (1999) Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 89:45–52.[ISI][Medline]

Petit TL, LeBoutillier JC, Alfano DP, Becker LE (1984) Synaptic development in the human fetus: a morphometric analysis of normal and Down's syndrome neocortex. Exp Neurol 83:13–23.[ISI][Medline]

Petit TL, LeBoutillier JC, Gregorio A, Libstug H (1988) The pattern of dendritic development in the cerebral cortex of the rat. Devl Brain Res 41:209–219.[ISI]

Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RC, Masuno M, Tommerup N, van Ommen GJ, Goodman RH, Peters DJ, et al. (1995) Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376:348–351.[ISI][Medline]

Pober BR, Filiano JJ (1995) Association of Chiari I malformation and Williams syndrome. Pediatr Neurol 12:84–88.[ISI][Medline]

Pogacar S, Nora NF, Kemper TL (1973) Neuropathological findings in Rubinstein-Taybi syndrome. R I Med J 56:114–121.[Medline]

Prinz M, Prinz B, Schulz E (1997) The growth of non-pyramidal neurons in the primary motor cortex of man: a Golgi study. Histol Histopathol 12:895–900.[ISI][Medline]

Purpura DP (1974) Dendritic spine ‘dysgenesis’ and mental retardation. Science 186:1126–1128.[ISI][Medline]

Purpura DP (1975a) Dendritic differentiation in human cerebral cortex: normal and aberrant developmental patterns. Adv Neurol 12:91–116.[ISI][Medline]

Purpura DP (1975b) Normal and aberrant neuronal development in the cerebral cortex of human fetus and young infant. UCLA Forum Med Sci 18:141–169.[Medline]

Purpura DP (1978) Ectopic dendritic growth in mature pyramidal neurones in human ganglioside storage disease. Nature 276:520–521.[ISI][Medline]

Purpura DP, Suzuki K (1976) Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res 116:1–21.[ISI][Medline]

Purpura DP, Bodick N, Suzuki K, Rapin I, Wurzelmann S (1982) Microtubule disarray in cortical dendrites and neurobehavioral failure. I. Golgi and electron microscopic studies. Brain Res 281: 287–297.[Medline]

Raymond GV, Bauman ML, Kemper TL (1996) Hippocampus in autism: a Golgi analysis. Acta Neuropathol (Berl) 91:117–119.[ISI][Medline]

Reiss AL, Faruque F, Naidu S, Abrams M, Beaty T, Bryan RN, Moser H (1993) Neuroanatomy of Rett syndrome: a volumetric imaging study. Ann Neurol 34:227–234.[ISI][Medline]

Rorke LB (1994) A perspective: the role of disordered genetic control of neurogenesis in the pathogenesis of migration disorders. J Neuropathol Exp Neurol 53:105–117.[ISI][Medline]

Rubinstein JH, Taybi H (1963) Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child 105:88–108.

Rudelli RD, Brown WT, Wisniewski K, Jenkins EC, Laure-Kamionowska M, Connell F, Wisniewski HM (1985) Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol (Berl) 67: 289–295.[ISI][Medline]

Schulz E, Scholz B (1992) Neurohistological findings in the parietal cortex of children with chromosome aberrations. J Hirnforsch 33:37–62.[ISI][Medline]

Sener RN (1995) Rubinstein-Taybi syndrome: cranial MR imaging findings. Comput Med Imag Graph 19:417–418.[ISI][Medline]

Stevens CA, Carey JC, Blackburn BL (1990) Rubinstein-Taybi syndrome: a natural history study. Am J Med Genet Suppl 6:30–37.[Medline]

Steward O, Bakker CE, Willems PJ, Oostra BA (1998) No evidence for disruption of normal patterns of mRNA localization in dendrites or dendritic transport of recently synthesized mRNA in FMR1 knockout mice, a model for human fragile-X mental retardation syndrome. NeuroReport 9:477–481.[ISI][Medline]

Stratling WH, Yu F (1999) Origin and roles of nuclear matrix proteins. Specific functions of the MAR-binding protein MeCP2/ARBP. Crit Rev Euk Gene Expr 9:311–318.[ISI][Medline]

Suetsugu M, Mehraein P (1980) Spine distribution along the apical dendrites of the pyramidal neurons in Down's syndrome. A quantitative Golgi study. Acta Neuropathol 50:207–210.[ISI][Medline]

Takashima S, Becker LE, Armstrong DL, Chan F (1981) Abnormal neuronal development in the visual cortex of the human fetus and infant with Down's syndrome. A quantitative and qualitative Golgi study. Brain Res 225:1–21.[ISI][Medline]

Takashima S, Becker LE, Chan F-W, Augustin R (1985) Golgi and computer morphometric analysis of cortical dendrites in metabolic storage disease. Exp Neurol 88:652–672.[ISI][Medline]

Takashima S, Ieshima A, Nakamura H, Becker LE (1989) Dendrites, dementia and the Down syndrome. Brain Dev 11:131–133.[ISI][Medline]

Takashima S, Iida K, Mito T, Arima M (1994) Dendritic and histochemical development and ageing in patients with Down's syndrome. J Intellect Disabil Res 38:265–273.[ISI][Medline]

Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, Dagna-Bricarelli F, Scartezzini P, Bertolini S, Mann DM, Tabaton M, Gambetti P (1996) Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nature Med 2:93–95.[ISI][Medline]

von Bossanyi P, Becher M (1990) Quantitative study of the dendritic spins of lamina V pyramidal neurons of the frontal lobe in children with severe mental retardation. J Hirnforsch 31:181–192.[ISI][Medline]

Wan M, Lee SS, Zhang X, Houwink-Manville I, Song HR, Amir RE, Budden S, Naidu S, Pereira JL, Lo IF, Zoghbi HY, Schanen NC, Francke U (1999) Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 65:1520–1529.[ISI][Medline]

Williams RS, Lott IT, Ferrante RJ (1977) The cellular pathology of neuronal ceroid-lipofuscinosis. A Golgi-electronmicroscopic study. Arch Neurol 34:298–305.[Abstract]

Williams RS, Ferrante RJ, Caviness VS (1978) The Golgi rapid method in clinical neuropathology: the morphologic consequences of suboptimal fixation. J Neuropathol Exp Neurol 37:13–33.[ISI][Medline]

Williams RS, Hauser SL, Purpura DP, De Long GR, Swisher CN (1980) Autism and mental retardation. Neuropathologic studies performed in four retarded persons with autistic behavior. Arch Neurol 37: 749–753.[Abstract]

Wisniewski KE (1990) Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am J Med Genet Suppl 7:274–281.[Medline]

Wisniewski KE, Kida E (1994) Abnormal neurogenesis and synaptogenesis in Down syndrome brain. Devl Brain Dysfunc 7:289–301.

Wisniewski KE, Laure-Kamionowska M, Connell F, Wisniewski HM (1985) Quantitative determination of synaptic density and their morphology during the postnatal development in visual cortex of Down syndrome brain. J Neuropathol Exp Neurol 44:342 (abstract).

Yan Y, Guan C, Leng L, Li J (1989) Quantitative histology study on brain nervous cells of neurological endemic cretins. In: Iodine and the brain (DeLong GR, Robbins J, Condliffe PG, eds), p. 359. New York: Plenum.